Caroline Albright

Caroline Albright

Fitch, Even, Tabin & Flannery LLP

Contact
View Bio
RSS

Latest Posts › Patent Infringement

Share:

Federal Circuit Will Not Read Safety and Efficacy Limitations into Pharma Method Claims

On July 24, in United Therapeutics Corporation v. Liquidia Technologies, Inc., the Federal Circuit addressed whether safety and efficacy are required for pharmaceutical method claims to be sufficiently enabled and supported...more

8/7/2023  /  Abbreviated New Drug Application (ANDA) , Efficacy Claims , Patent Infringement , Patent Validity , Pharmaceutical Industry , Safety Precautions , Written Descriptions
1 Results
 / 
View per page
Page: of 1

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
Sign up Log in
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
- hide
- hide